Cardiomyopathies are a heterogeneous group of myocardial disorders of mostly unknown
etiology, and they occur commonly in cats. In some cats, they are well‐tolerated and are …

Practical relevance: Hypertrophic cardiomyopathy (HCM) is the most common form of feline
cardiomyopathy observed clinically and may affect up to approximately 15% of the domestic …

Objectives Hypertrophic cardiomyopathy (HCM) appears to be common in cats and, based
on pilot data, a prevalence of 15% has been hypothesized. The objectives were to screen a …

Background Left atrial (LA) enlargement, congestive heart failure (CHF), and aortic
thromboembolism (ATE) are associated with decreased survival in cats with hypertrophic …

Background Echocardiography is a cost‐efficient method to screen cats for presence of
heart disease. Current reference intervals for feline cardiac dimensions do not account for …

Objectives To evaluate risk factors associated with different types of cardiac death in cats
with hypertrophic cardiomyopathy (HCM). Animals Two hundred fifty-five cats with HCM …

BACKGROUND: Circulating plasma N-terminal pro-brain natriuretic peptide (NT-proBNP)
concentration facilitates emergency diagnosis of congestive heart failure (CHF) in people. Its …

OBJECTIVES: This pilot study was performed to investigate murmur prevalence and to
explore the association between auscultatory and echocardiographic findings in apparently …

Background: B‐type natriuretic peptide concentrations reliably distinguish between cardiac
and respiratory causes of dyspnea, but its utility to detect asymptomatic cats with occult …

Background The natural history of hypertrophic cardiomyopathy (HCM) in cats has been
mainly studied in cats referred for suspected heart disease, which can skew the results …